Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-14 of 14 for your search:
Cancer Type/Condition:
Osteosarcoma
Stage/Subtype:
localized osteosarcoma
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 to 65
Sponsor:
Other
Protocol IDs:
382
, NCT00691236
2.
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
5 to 40 at diagnostic biopsy
Sponsor:
NCI
Protocol IDs:
COG-AOST0331
, AOST0331, NCT00134030, ISRCTN67613327, EU-20530, MRC-EURAMOS1, MRC-BO08, EUDRACT-2004-000242-20
3.
Combination Chemotherapy With or Without Zoledronic Acid in Treating Patients With Osteosarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
5 to 50
Sponsor:
Other, Pharmaceutical / Industry
Protocol IDs:
FRE-FNCLCC-SARCOME-09-0603
, FRE-FNCLCC-OS-2006, NOVARTIS-FRE-FNCLCC-SARCOME-09-0603, CHUGAI-FRE-FNCLCC-SARCOME-09-0603, EU-20729, EUDRACT-2006-00337727, SARCOME 09/0603, NCT00470223
4.
A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
30 and under
Sponsor:
NCI, Other
Protocol IDs:
OS2008
, NCT00667342
5.
Radiation Therapy to Treat Musculoskeletal Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
25 and under
Sponsor:
Other
Protocol IDs:
RTSARC
, NCT00186992
6.
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Any age
Sponsor:
NCI
Protocol IDs:
CINJ-3330
, NCT00161187
7.
Proton Radiation for the Treatment of Pediatric Bone and Non-Rhabdomyosarcoma Soft Tissue Sarcomas
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
30 and under
Sponsor:
NCI, Other
Protocol IDs:
05-326
, NCT00592293
8.
Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs’ Girdle
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
16 and over
Sponsor:
Other
Protocol IDs:
PIP
, CSET 2003/1053, NCT00181025
9.
Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
UCLA-0704086
, 07-04-086, BAYER-UCLA-0704086, ONYX-UCLA-0704086, NCT00880542
10.
A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
12 to 60
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
SIM-65
, NCT01002092
11.
Randomized, Double Blind, Placebo-Controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
NYU 05-409
, NCT00821652
12.
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Over 18
Sponsor:
NCI
Protocol IDs:
JHOC-J0685
, NA_00003073, J0685, NCT00499733
13.
Cytogenetic and Molecular Genetic Studies in Bone Sarcomas
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
93-141
, NCT00579930
14.
Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
5 to 40
Sponsor:
Other
Protocol IDs:
2007-0404
, NCT00673179
Select All on Page
Help with Results
